drugset / Trial / NCT06522100

Corticoid Therapy in Acute Myocarditis

NCT06522100

Phase 3 Not yet recruiting 420 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Refer to the "Detailed Description" section.

Timeline

Start
2025-02-01
Primary completion
2028-08-16
Completion
2028-08-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 500 mg Intravenous
Subject Prednisone Other / unclassified 10 mg Oral

Indications